Free Trial

Theseus Pharmaceuticals (THRX) Insider Trading & Ownership

→ The Next Step of Their Control Is Here … (From Weiss Ratings) (Ad)
Free THRX Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Stock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSocial Media

Theseus Pharmaceuticals (NASDAQ:THRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
46.70%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$3.54 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get THRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Theseus Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

THRX Insider Buying and Selling by Quarter

Ad Weiss Ratings
Protect Yourself While There’s Still Time …
The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.
4 simple steps to protect your privacy and money before it’s too late.

Theseus Pharmaceuticals Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/17/2023Carl L GordonDirectorBuy479,932$3.05$1,463,792.60  
7/17/2023Foresite Capital Management V,Major ShareholderBuy700,000$2.97$2,079,000.00  
(Data available from 1/1/2013 forward)

THRX Insider Trading Activity - Frequently Asked Questions

Who is on Theseus Pharmaceuticals's Insider Roster?

The list of insiders at Theseus Pharmaceuticals includes Bradford D Dahms, Carl L Gordon, Foresite Capital Management V,, and Timothy P Clackson. Learn more on insiders at THRX.

What percentage of Theseus Pharmaceuticals stock is owned by insiders?

46.70% of Theseus Pharmaceuticals stock is owned by insiders. Learn more on THRX's insider holdings.

Which Theseus Pharmaceuticals insiders have been buying company stock?

The following insiders have purchased THRX shares in the last 24 months: Bradford D Dahms ($10,003.32), Carl L Gordon ($2,464,112.60), and Foresite Capital Management V, ($2,079,000.00).

How much insider buying is happening at Theseus Pharmaceuticals?

Insiders have purchased a total of 1,373,434 THRX shares in the last 24 months for a total of $4,553,115.92 bought.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:THRX) was last updated on 4/26/2024 by MarketBeat.com Staff

From Our Partners
These AI trades triggered this morning (545% return)
Prosper Trading Academy
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Fed launches fourth dollar overhaul
Stansberry Research
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace
Exposed: 10 CENT Crypto to Explode April 20th?
True Market Insiders
A.I. is a Tidal Wave - Here’s What to Buy
Chaikin Analytics